Trials / Terminated
TerminatedNCT01667029
Study of Sulfasalazine in Treating Painful Neuropathy
A Single-center, Randomized, Double-blind Clinical Study to Evaluate the Effect of Sulfasalazine on Painful Neuropathy
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that sulfasalazine, an FDA-approved medication for rheumatoid arthritis and ulcerative colitis, may be beneficial in neuropathic pain conditions. In this study, the investigators will evaluate whether sulfasalazine improves pain due to painful peripheral neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sulfasalazine | |
| DRUG | placebo |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2017-08-10
- Completion
- 2017-08-10
- First posted
- 2012-08-17
- Last updated
- 2018-08-22
- Results posted
- 2018-08-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01667029. Inclusion in this directory is not an endorsement.